Trials / Completed
CompletedNCT02899884
Characterisation and Epidemiology of Breakthrough Cancer Pain in Spain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,765 (actual)
- Sponsor
- Takeda · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the prevalence of breakthrough cancer pain and characterize breakthrough cancer pain in an unselected, representative cohort of cancer outpatients with or without pain who attend consultations.
Detailed description
This study has been designed as a non-interventional, non post-authorization, cross-sectional, epidemiological study to determine the prevalence of breakthrough cancer pain and characterize breakthrough cancer pain in an non-selected, representative cohort of cancer outpatients with or without pain. The study enrolled 3765 patients. This multicenter trial will be conducted in Spain. Data from participants will be collected through questionnaire and medical history in a single visit (up to 1 month).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention |
Timeline
- Start date
- 2016-11-14
- Primary completion
- 2018-04-04
- Completion
- 2018-07-16
- First posted
- 2016-09-14
- Last updated
- 2019-11-22
- Results posted
- 2019-11-22
Locations
36 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02899884. Inclusion in this directory is not an endorsement.